Spirapril Hydrochloride

盐酸螺普利

Report date: 2022/08/17 13:57:32
NME

Base Information

Drug NameSpirapril Hydrochloride
Drug Alias NameQuadropril司派普利螺普利CardioprilRenpress +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1994/12/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaPending
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC09AA11